Genetic factors influencing anti-epidermal growth factor receptor (EGFR) antibody toxicity to the skin

被引:0
|
作者
Jaka, A. [1 ]
Ormaechea, N. [1 ]
Gutierrez-Rivera, A. [1 ]
Vildosola, S. [1 ]
Lopez-Pestana, A. [1 ]
Sarasqueta, C. [2 ]
La Casta, A. [1 ]
Izeta, A. [1 ]
Tuneu, A. [1 ]
机构
[1] Hosp Univ Donostia, San Sebastian, Spain
[2] Hosp Univ Donostia, Res Unit, San Sebastian, Spain
关键词
D O I
暂无
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
1069
引用
收藏
页码:S182 / S182
页数:1
相关论文
共 50 条
  • [1] Biomarkers of skin toxicity induced by anti-epidermal growth factor receptor antibody treatment in colorectal cancer
    Akiko Kubo
    Hironobu Hashimoto
    Naoki Takahashi
    Yasuhide Yamada
    World Journal of Gastroenterology, 2016, (02) : 887 - 894
  • [2] Biomarkers of skin toxicity induced by anti-epidermal growth factor receptor antibody treatment in colorectal cancer
    Kubo, Akiko
    Hashimoto, Hironobu
    Takahashi, Naoki
    Yamada, Yasuhide
    WORLD JOURNAL OF GASTROENTEROLOGY, 2016, 22 (02) : 887 - 894
  • [3] Anti-epidermal growth factor receptor skin toxicity: a matter of topical hydration
    Ferrari, Daris
    Codeca, Carla
    Bocci, Barbara
    Crepaldi, Francesca
    Violati, Martina
    Viale, Giulia
    Careri, Carmela
    Caldiera, Sarah
    Bordin, Veronica
    Luciani, Andrea
    Zonato, Sabrina
    Cassinelli, Gabriela
    Foa, Paolo
    ANTI-CANCER DRUGS, 2016, 27 (02) : 144 - 146
  • [4] Hypomagnesaemia and targeted anti-epidermal growth factor receptor (EGFR) agents
    Andreia Costa
    Sabine Tejpar
    Hans Prenen
    Eric Van Cutsem
    Targeted Oncology, 2011, 6 : 227 - 233
  • [5] Association between serum ligands and the skin toxicity of anti-epidermal growth factor receptor antibody in metastatic colorectal cancer
    Takahashi, Naoki
    Yamada, Yasuhide
    Furuta, Koh
    Nagashima, Kengo
    Kubo, Akiko
    Sasaki, Yusuke
    Shoji, Hirokazu
    Honma, Yoshitaka
    Iwasa, Satoru
    Okita, Natsuko
    Takashima, Atsuo
    Kato, Ken
    Hamaguchi, Tetsuya
    Shimada, Yasuhiro
    CANCER SCIENCE, 2015, 106 (05) : 604 - 610
  • [6] Preclinical studies predicting low clinical toxicity of the anti-epidermal growth factor receptor (EGFR) monoclonal antibody (mAb) nimotuzumab
    Casaco, Angel
    Ledon, Nuris
    Iznaga-Escobar, Normando
    Elena Arteaga, Maria
    Crombet, Tania
    TOXICOLOGY LETTERS, 2008, 180 : S209 - S209
  • [7] Hypomagnesaemia and targeted anti-epidermal growth factor receptor (EGFR) agents
    Costa, Andreia
    Tejpar, Sabine
    Prenen, Hans
    Van Cutsem, Eric
    TARGETED ONCOLOGY, 2011, 6 (04) : 227 - 233
  • [8] Impact and management of skin toxicity associated with anti-epidermal growth factor receptor therapy: Survey results
    Boone, Susan L.
    Rademaker, Alfred
    Liu, Dachao
    Pfeiffer, Carmen
    Mauro, David J.
    Lacouture, Mario E.
    ONCOLOGY, 2007, 72 (3-4) : 152 - 159
  • [9] Analysis of risk factors for skin disorders caused by anti-epidermal growth factor receptor antibody drugs and examination of methods for their avoidance
    Takahashi, Hiroaki
    Asaka, Junichi
    Tairabune, Tomohiko
    Ujiie, Haruki
    Matsuura, Yukiko
    Nihei, Satoru
    Kimura, Toshimoto
    Chiba, Takeshi
    Kudo, Kenzo
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2021, 46 (05) : 1404 - 1411
  • [10] Effects of the anti-epidermal growth factor receptor antibody cetuximab on cholangiocarcinoma of the liver
    Huang, Tsai-Wang
    Wang, Chih-Hsin
    Hsieh, Chung-Bao
    ONKOLOGIE, 2007, 30 (03): : 129 - 131